BCL2 and androgenetic alopecia: Previous researches reveal that EGCG ameliorates androgenic alopecia by selectively inhibiting 5α-reductase activity, and up-regulating phosphorylated Erk and Akt and increasing the Bcl-2/Bax ratio on DPCs [35].